Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://neurosciencenews.com/anti-amyloid-alzheimers-medication-22754/
0
0
Investigational Anti-amyloid Treatment Started Before Alzheimer’s Symptoms Did Not Slow Memory Loss - Neuroscience News
3/9/23 at 3:15pm
Organization
Neurosciencenews.com
Author
Neuroscience News
Details
34 words
Summarize
Neurological Conditions
Aging & Geriatrics
Business & Industrial
Symptoms Did Not Slow Memory Loss - Neuroscience News Solanezumab
Solanezumab, an investigational anti-amyloid treatment, does not significantly slow the cognitive decline associated with Alzheimer's disease.
Show more
1 similar article
Eli Lilly Alzheimer's treatment solanezumab failed to slow disease progression - CNBC
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...